Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis
Xin Dong,Nan Li,Rui-jia Wen,Hao-wen Zhuang,Feng-xiang Pang,Shou-chang Ding,Yong-xin Mai,Shu-ting Zhou,Jun-yan Wang,Jin-fang Zhang
DOI: https://doi.org/10.1016/j.phymed.2023.154881
IF: 6.656
2023-05-14
Phytomedicine
Abstract:Background : Osteosarcomas (OS) is a kind of malignant bone tumor which occurs primarily in children and adolescents, and the clinical therapeutics remain disappointing. As a new programmed cell death, ferroptosis is characterized by iron dependent and intracellular oxidative accumulation, which provides a potential alternative intervene for the OS treatment. Baicalin, a major bioactive flavone derived from traditional Chinese medicine Scutellaria baicalensis, has been proved to have anti-tumor properties in OS. Whether ferroptosis participated in the baicalin mediated anti-OS activity is an interesting project. Purpose : To explore the pro-ferroptosis effect and mechanisms of baicalin in OS. Methods/Study Design : Pro-ferroptosis effect of baicalin on cell death, cell proliferation, iron accumulation, lipid peroxidation production was determined in MG63 and 143B cells. The levels of glutathione (GSH), oxidized ( GSSG ) glutathione and malondialdehyde (MDA) were determined by enzyme linked immunosorbent assay ( ELISA) . The expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), Glutathione peroxidase 4 (GPX4) and xCT were detected by western blot in baicalin-mediated ferroptosis regulation. In vivo , a xenograft mice model was adopted to explore the anticancer effect of baicalin. Results : In the present study, it was found that baicalin significantly suppress tumor cell growth in vitro and in vivo . By promoting the Fe accumulation, ROS formation, MDA production and suppressing the ratio of GSH/GSSG, baicalin was found to trigger ferroptosis in OS and ferroptosis inhibitor ferrostatin-1 (Fer-1) successfully reversed these suppressive effects, indicating that ferroptosis participated in the baicalin mediated anti-OS activity. Mechanistically, baicalin physically interacted with Nrf2, a critical regulator of ferroptosis, and influenced its stability via inducing ubiquitin degradation, which suppressed the Nrf2 downstream targets GPX4 and xCT expression, and led to stimulating ferroptosis. Conclusions : Our findings for the first time indicated that baicalin exerted anti-OS activity through a novel Nrf2/xCT/GPX4-dependent ferroptosis regulatory axis, which hopefully provides a promising candidate for OS treatment.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences